These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32855208)

  • 1. Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer.
    Przanowski P; Lou S; Tihagam RD; Mondal T; Conlan C; Shivange G; Saltani I; Singh C; Xing K; Morris BB; Mayo MW; Teixeira L; Lehmann-Che J; Tushir-Singh J; Bhatnagar S
    Cancer Res; 2020 Nov; 80(21):4791-4804. PubMed ID: 32855208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM37 orchestrates renal cell carcinoma progression via histone H2A ubiquitination-dependent manner.
    Miao C; Liang C; Li P; Liu B; Qin C; Yuan H; Liu Y; Zhu J; Cui Y; Xu A; Wang S; Su S; Li J; Shao P; Wang Z
    J Exp Clin Cancer Res; 2021 Jun; 40(1):195. PubMed ID: 34130705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein.
    Bhatnagar S; Gazin C; Chamberlain L; Ou J; Zhu X; Tushir JS; Virbasius CM; Lin L; Zhu LJ; Wajapeyee N; Green MR
    Nature; 2014 Dec; 516(7529):116-20. PubMed ID: 25470042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM37 controls cancer-specific vulnerability to PLK4 inhibition.
    Meitinger F; Ohta M; Lee KY; Watanabe S; Davis RL; Anzola JV; Kabeche R; Jenkins DA; Shiau AK; Desai A; Oegema K
    Nature; 2020 Sep; 585(7825):440-446. PubMed ID: 32908304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression.
    Hu X; Xiang D; Xie Y; Tao L; Zhang Y; Jin Y; Pinello L; Wan Y; Yuan GC; Li Z
    Oncogene; 2019 Oct; 38(44):7017-7034. PubMed ID: 31409898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM37 Promotes Pancreatic Cancer Progression through Modulation of Cell Growth, Migration, Invasion, and Tumor Immune Microenvironment.
    Do TT; Yeh CC; Wu GW; Hsu CC; Chang HC; Chen HC
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-κB Signaling.
    Wu G; Song L; Zhu J; Hu Y; Cao L; Tan Z; Zhang S; Li Z; Li J
    Cancer Res; 2018 Nov; 78(22):6399-6412. PubMed ID: 30254148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanobubble-mediated co-delivery of siTRIM37 and IR780 for gene and sonodynamic combination therapy against triple negative breast cancer.
    He X; Zhang S; Tian Y; Dong J; Yuan Y; Jing H
    Biomed Mater; 2024 Oct; 19(6):. PubMed ID: 39312939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM37 Augments AP-2γ Transcriptional Activity and Cellular Localization via K63-linked Ubiquitination to Drive Breast Cancer Progression.
    Cui G; Gao Z; Chang S; Narwade N; Chen Y; Poudel B; Lei KMK; Zhang W; Li G; Poon TCW; Cheung E
    Int J Biol Sci; 2022; 18(11):4316-4328. PubMed ID: 35864973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM37 negatively regulates inflammatory responses induced by virus infection via controlling TRAF6 ubiquitination.
    Zhao L; Hao Y; Song Z; Fan Y; Li S
    Biochem Biophys Res Commun; 2021 Jun; 556():87-92. PubMed ID: 33839419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway.
    Tan G; Xie B; Yu N; Huang J; Zhang B; Lin F; Li H
    Int J Clin Oncol; 2021 Mar; 26(3):532-542. PubMed ID: 33387087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models.
    Sabol RA; Bowles AC; Côté A; Wise R; O'Donnell B; Matossian MD; Hossain FM; Burks HE; Del Valle L; Miele L; Collins-Burow BM; Burow ME; Bunnell BA
    Breast Cancer Res; 2019 May; 21(1):67. PubMed ID: 31118047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy.
    Foidart P; Yip C; Radermacher J; Blacher S; Lienard M; Montero-Ruiz L; Maquoi E; Montaudon E; Château-Joubert S; Collignon J; Coibion M; Jossa V; Marangoni E; Noël A; Sounni NE; Jerusalem G
    Clin Cancer Res; 2019 Mar; 25(6):1838-1850. PubMed ID: 30504427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells.
    Mani C; Jonnalagadda S; Lingareddy J; Awasthi S; Gmeiner WH; Palle K
    Breast Cancer Res; 2019 Sep; 21(1):104. PubMed ID: 31492187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
    Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
    Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells.
    Ogbu SC; Rojas S; Weaver J; Musich PR; Zhang J; Yao ZQ; Jiang Y
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    Fatima I; El-Ayachi I; Taotao L; Lillo MA; Krutilina RI; Seagroves TN; Radaszkiewicz TW; Hutnan M; Bryja V; Krum SA; Rivas F; Miranda-Carboni GA
    PLoS One; 2017; 12(12):e0189864. PubMed ID: 29281678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer.
    Bousquet G; El Bouchtaoui M; Sophie T; Leboeuf C; de Bazelaire C; Ratajczak P; Giacchetti S; de Roquancourt A; Bertheau P; Verneuil L; Feugeas JP; Espié M; Janin A
    Oncotarget; 2017 May; 8(21):35205-35221. PubMed ID: 28445132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-(4-Hydroxy-3-methoxyphenyl)-benzothiazole suppresses tumor progression and metastatic potential of breast cancer cells by inducing ubiquitin ligase CHIP.
    Hiyoshi H; Goto N; Tsuchiya M; Iida K; Nakajima Y; Hirata N; Kanda Y; Nagasawa K; Yanagisawa J
    Sci Rep; 2014 Nov; 4():7095. PubMed ID: 25403352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.